AU Patent

AU2004228782A1 — Methods for treatment of Parkinson's Disease

Assigned to Newron Pharmaceuticals SpA · Expires 2004-10-21 · 22y expired

What this patent protects

Patent listed against safinamide-mesylate.

Drugs covered by this patent

Patent Metadata

Patent number
AU2004228782A1
Jurisdiction
AU
Classification
—
Expires
2004-10-21
Drug substance claim
No
Drug product claim
No
Assignee
Newron Pharmaceuticals SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.